Related Experiment Video
Updated: Jun 7, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Could uric acid have a pathogenic role in pre-eclampsia?
Annabel C Martin1, Mark A Brown
1Department of Renal Medicine & Medicine, University of New South Wales, Sydney, NSW 2217, Australia.
Insights
Uric acid levels rise with pre-eclampsia severity, potentially worsening endothelial dysfunction. Monitoring uric acid may aid future pre-eclampsia treatment strategies.
Area of Science:
- Obstetrics and Gynecology
- Nephrology
- Cardiovascular Disease
Background:
- Pre-eclampsia involves hypertension, endothelial dysfunction, and renal dysfunction.
- Uric acid's role in pre-eclampsia pathogenesis is under renewed investigation.
- Elevated uric acid levels correlate with pre-eclampsia severity.
Purpose of the Study:
- To explore the role of uric acid in pre-eclampsia development and progression.
- To understand the mechanisms by which uric acid may contribute to pre-eclampsia pathology.
- To evaluate the diagnostic and potential therapeutic relevance of uric acid in pre-eclampsia.
Main Methods:
- Review of existing literature on uric acid and pre-eclampsia.
- Analysis of the relationship between plasma uric acid levels and disease severity.
- Investigation of uric acid's in vitro effects on endothelial cells and oxidative stress.
Main Results:
- Uric acid levels increase with pre-eclampsia manifestation and severity.
- Hyperuricemia in pre-eclampsia may stem from increased production (trophoblast breakdown, cytokines, ischemia) and reduced renal clearance.
- Uric acid can induce endothelial dysfunction, inflammation, and oxidation, but also acts as an antioxidant.
Conclusions:
- Uric acid may propagate pre-eclampsia pathology through endothelial damage and inflammation.
- Plasma urate measurements currently support pre-eclampsia diagnosis.
- Further research may establish uric acid monitoring as crucial for pre-eclampsia treatment.
Abstract:
Interest has been renewed over the role of uric acid in the pathogenesis of hypertension, endothelial dysfunction and renal dysfunction, which are all features of pre-eclampsia. Uric acid is not a consistent predictive factor for the development of pre-eclampsia but its levels generally increase once the disease manifests, and plasma levels of uric acid approximately correlate with disease severity. Hyperuricemia in pre-eclampsia was once thought to result solely from reduced renal clearance, but levels of uric acid are now also thought to increase through increased uric acid production caused by trophoblast breakdown, cytokine release and ischemia. Uric acid can promote endothelial dysfunction, damage and inflammation, which leads to oxidation. Pre-eclampsia, which is characterized by widespread endothelial dysfunction and inflammation, might be propagated by uric acid through these known in vitro activities. Of note, however, uric acid can also act as a scavenger of oxygen free radicals. Plasma urate measurements are currently used to support the diagnosis of pre-eclampsia during pregnancy. As further studies define the role of uric acid in the development of pre-eclampsia, monitoring levels of this factor may again become essential to the future treatment of pre-eclampsia.
Related Concept Videos
Hormonal Regulation
Teratogenicity
Urine Studies I: Urinalysis
Hepatic Encephalopathy
Nephrotic Syndrome I : Introduction